menu
    • menu

    Company profile for Nocion Therapeutics

    NEW Drugs in Dev: 5
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nocion Therapeutics is a biopharmaceutical company developing novel treatments for silencing neurons. The company’s platform of unique molecular entities selectively affects inflamed nociceptors. Treatment using this approach aims to provide more durable and robust local analgesic effects while minimizing numbness or paralysis and other systemic off-target effects. The company’s mission is to safely alleviate suffering for...
    Nocion Therapeutics is a biopharmaceutical company developing novel treatments for silencing neurons. The company’s platform of unique molecular entities selectively affects inflamed nociceptors. Treatment using this approach aims to provide more durable and robust local analgesic effects while minimizing numbness or paralysis and other systemic off-target effects. The company’s mission is to safely alleviate suffering for millions of patients with conditions arising from activated sensory neurons including chronic cough, pain and itch.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nocion TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Beaver Street, Suite 308 Waltham, MA 02453
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nociontx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nocion-therapeutics-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nocion Therapeutics Completes Enrollment in Phase 2b ASPIRE Trial
    Nocion Therapeutics Completes Enrollment in Phase 2b ASPIRE Trial

    05 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260504809410/en/Nocion-Therapeutics-Announces-Full-Enrollment-in-Phase-2b-ASPIRE-Study-of-Taplucainium-for-Chronic-Cough

    BUSINESSWIRE
    05 May 2026
    Share Share
    Nocion Strengthens Board of Directors with Appointment of Mark
    Nocion Strengthens Board of Directors with Appointment of Mark

    01 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-01/nocion-therapeutics-strengthens-board-of-directors-with-appointment-of-mark-iwicki

    PHARMIWEB
    01 Apr 2026
    Share Share
    Nocion Therapeutics Showcases Nocions Pain Treatment Approach
    Nocion Therapeutics Showcases Nocions Pain Treatment Approach

    26 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260126173085/en/Nocion-Therapeutics-to-Present-Preclinical-Data-Supporting-Nocions-as-a-Novel-Approach-for-the-Treatment-of-Pain-at-the-Non-Opioid-Pain-Therapeutics-Summit

    BUSINESSWIRE
    26 Jan 2026
    Share Share
    Nocion Therapeutics Boosts Series B Funding To $93M
    Nocion Therapeutics Boosts Series B Funding To $93M

    07 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-07/nocion-therapeutics-extends-series-b-financing-to-93-million-to-support-late-stage-development-of-t

    PHARMIWEB
    07 Jan 2026
    Share Share
    Nocion Therapeutics Appoints Matthew as Chief Medical Officer
    Nocion Therapeutics Appoints Matthew as Chief Medical Officer

    28 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250428350347/en/Nocion-Therapeutics-Appoints-Matthew-Frankel-M.D.-MBA-to-Chief-Medical-Officer

    BUSINESSWIRE
    28 Apr 2025
    Share Share
    Nocion Doses 1st Patient in ASPIRE Ph 2b Chronic Cough Study
    Nocion Doses 1st Patient in ASPIRE Ph 2b Chronic Cough Study

    18 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241118528509/en

    BUSINESSWIRE
    18 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search